China Pharma Holdings (CPHI) Receivables (2016 - 2025)
Historic Receivables for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $355789.0.
- China Pharma Holdings' Receivables fell 9751.47% to $355789.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $355789.0, marking a year-over-year decrease of 9751.47%. This contributed to the annual value of $13.8 million for FY2024, which is 414.48% down from last year.
- Latest data reveals that China Pharma Holdings reported Receivables of $355789.0 as of Q3 2025, which was down 9751.47% from $14.0 million recorded in Q2 2025.
- China Pharma Holdings' Receivables' 5-year high stood at $14.4 million during Q4 2023, with a 5-year trough of $275244.0 in Q2 2023.
- In the last 5 years, China Pharma Holdings' Receivables had a median value of $1.9 million in 2021 and averaged $5.9 million.
- Per our database at Business Quant, China Pharma Holdings' Receivables skyrocketed by 498261.29% in 2024 and then plummeted by 9751.47% in 2025.
- China Pharma Holdings' Receivables (Quarter) stood at $2.1 million in 2021, then tumbled by 78.94% to $450670.0 in 2022, then surged by 3106.0% to $14.4 million in 2023, then decreased by 4.14% to $13.8 million in 2024, then crashed by 97.43% to $355789.0 in 2025.
- Its Receivables was $355789.0 in Q3 2025, compared to $14.0 million in Q2 2025 and $14.0 million in Q1 2025.